An Open-Label, Prospective, Pilot Study of Hypertonic Saline for Hidradenitis Suppurativa.

Background: Hidradenitis suppurativa (HS) fistulas are likely to persist without surgical intervention. Hypertonic saline (HTS), a venous sclerosant, disrupts the endothelial lining leading to occlusion and fibrosis when used for venous insufficiency.

Objective: To evaluate the efficacy and tolerability of HTS sclerotherapy for HS fistulas.

Sunscreen recommendations for patients with skin of color in the popular press and in the dermatology clinic.

Background: Patients with skin of color are at risk for skin cancer, pigmentary disorders, and photo-exacerbated conditions but find it challenging to use sunscreens on the market that leave an obvious residue on their skin.

Objective: The objective of this study was to examine sunscreen recommendations from the popular press and from practicing dermatologists for patients with skin of color.

Methods: We queried the Google search engine with the following search terms: "Sunscreen" with "skin of color," "dark skin," "black skin.

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa.

Background: Methotrexate is an immunomodulatory therapy that may offer benefit to patients with hidradenitis suppurativa (HS). Despite its theoretical advantages, there is a paucity of available data regarding long-term methotrexate use in patients with HS.

Objective: This study aimed to assess whether methotrexate treatment leads to improvement in HS disease severity.